Track topics on Twitter Track topics that are important to you
Researchers at University of California, San Diego School of Medicine have established the safety and dosing of a new drug for treating blood cancers. The findings are published online July 27 in The Lancet Haematology.
After a battle with Alzheimer’s disease, audio engineering pioneer Ray Dolby died in 2013. Now his family is using the fortune he left behind to help find treatments that take a different tack than much of the work in the field to date. Through...
ConsortiEX, a healthcare IT startup with roots in both Wisconsin and Massachusetts, has closed a $1 million funding round led by Open Prairie Ventures, the company announced today. ConsortiEX developed an ordering and tracking software system for the...
I need to confess that at the start that I am suspicious when a pharmaceutical company offers to pay for anything on behalf of patients. Such programs usually have a strong link to the company's bottom line. I cite as evidence my previous note about ...
UC San Diego Health, with the University of California, San Diego School of Medicine, has entered into a multi-year affiliation agreement with La Jolla Institute for Allergy and Immunology (LJI) designed to deepen existing collaborative relationships, boost basic research of diseases of the immune system and more quickly introduce new clinical treatments and therapies.
The biotech valuations are getting hit. This is no surprise. We have some mild surprise that this didn't happen earlier in the Summer. It's the traditional time for the doldrums on the street.Nevertheless, barring a national malaise, we expect to come out of it faster than the usual bubble bursting.A while back, we wrote our series on "The Biotech Bubble". For a number of reasons, we think it will...
Titan Pharmaceuticals (OTCQB:TTNP) will ask shareholders at the annual meeting on Aug. 24 for approval of a reverse stock split within the range of 1-for-3 and 1-for-8 at any time prior to June 30, 2016. “We believe that enabling our board to set the ratio within the stated range will provide us with the flexibility […]
La Jolla Institute's basic science in immunology complement UCSD's clinical prowess.
Shire remains on track for 2016 and 2020 sales targets, CEO says, as second quarter flatness was caused by foreign exchange impacts and generic competition to ADHD drug Intuniv.
Twenty-five years after he pled guilty to taking payments from companies, former FDA review chemist David Brancato gets FDA to terminate his debarment; several industry execs won terminations years ago.
Scientists have identified a critical function of what they believe to be schizophrenia's "Rosetta Stone" gene that could hold the key to decoding the function of all genes involved in the disease. The breakthrough has revealed a vulnerable period in...
On Friday, July 24, Superior Court Judge Judith F. Hayes found in favor of the University of California Regents’ request for a preliminary injunction to restore rightful custody and control of Alzheimer’s Disease Cooperative Study (ADCS) data to UC San Diego.
France will eliminate industry seat on the nation's HTA transparency panel, in apparent continuing Mediator fall-out.
A guest column by the American College of Physicians, exclusive to KevinMD.com. In the spring of 2009, I represented the American College of Physicians (ACP) at a meeting in Washington of health policy experts discussing payment reform. When I arrived at the cocktail reception the night before the meeting, a well-known medical leader not known to be […]
Here are headlines from the past week in North Carolina biotech and cleantech news. —A Chimerix (NASDAQ: CMRX) antiviral being studied as a smallpox countermeasure showed positive results in a trial evaluating the drug in animals. The Durham co...
It’s been a tumultuous few years for Aegerion Pharmaceuticals, marred by a stalled drug launch, the rise of new competitors, and a plummeting stock. And today its embattled CEO is leaving the company. Cambridge, MA-based Aegerion (NASDAQ: AEGR) sai...
CBMG Receives CFDA OK for Non-Cryopreservation Cell & Tissue Kits CBMG Closes Acquisition of CD40LGVAX Lung Cancer Vaccine Combo Trial with Bristol-Myers Nivolumab PD-1 at Moffitt for U.S. Market Download Full 11-Page Note with Important Disclosures: Morning Note 07-27-15 CBMG The recent focus for CBMG has been on their immuno-oncology pipeline for CAR-T (CD19, CD20, CD30, EGFR/HER1) and the r...
Amarantus Diagnostics, a unit of Amarantus BioScience Holdings (OTCQX:AMBS), has established a three-person strategic advisory committee (SAC) to focus on advancing and deriving the full value of the company’s diagnostics business. Amarantus Diagnostics is developing tests for multiple sclerosis and Alzheimer’s disease. The SAC includes Philippe Goix, Steven Guillen and Brian Ward. ...